Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
Sales | 5,464,000 | 5,965,000 | 5,811,000 | 5,688,000 | 5,527,000 |
Cost of Goods | 996,000 | 1,067,000 | 1,027,000 | 1,050,000 | 1,018,000 |
Gross Profit | 4,468,000 | 4,898,000 | 4,784,000 | 4,638,000 | 4,509,000 |
Operating Expenses | 1,877,000 | 2,413,000 | 2,257,000 | 2,258,000 | 2,107,000 |
Operating Income | 2,591,000 | 2,485,000 | 2,527,000 | 2,380,000 | 2,402,000 |
Interest Expense | 326,000 | 328,000 | 325,000 | 313,000 | 294,000 |
Other Income | 195,000 | 126,000 | 216,000 | 137,000 | 150,000 |
Pre-tax Income | 2,460,000 | 2,283,000 | 2,418,000 | 2,204,000 | 2,258,000 |
Income Tax | 389,000 | 348,000 | 401,000 | 334,000 | 358,000 |
Net Income Continuous | 2,071,000 | 1,935,000 | 2,017,000 | 1,870,000 | 1,900,000 |
Net Income | $2,071,000 | $1,935,000 | $2,017,000 | $1,870,000 | $1,900,000 |
EPS Basic Total Ops | 2.81 | 2.61 | 2.70 | 2.49 | 2.52 |
EPS Basic Continuous Ops | 2.81 | 2.61 | 2.70 | 2.49 | 2.52 |
EPS Diluted Total Ops | 2.79 | 2.59 | 2.68 | 2.47 | 2.50 |
EPS Diluted Continuous Ops | 2.79 | 2.59 | 2.68 | 2.47 | 2.50 |
EBITDA(a) | $3,115,000 | $3,044,000 | $3,030,000 | $2,902,000 | $2,923,000 |